Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective, Longitudinal Natural History Study of Subjects With ENPP1 Deficiency or the Early-Onset Form of ABCC6 Deficiency

NCT07745179 is registered in ClinicalTrials.gov with Inozyme Pharma as lead sponsor.

NCT NCT07745179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07745179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective, Longitudinal Natural History Study of Subjects With ENPP1 Deficiency or the Early-Onset Form of ABCC6 Deficiency
Lead sponsor
Inozyme Pharma
Phase
Observational
Overall status
Completed
Start date
December 5, 2018
Completion date
February 14, 2025
Enrollment
23 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

atp-binding cassette subfamily c member 6 deficiency, autosomal recessive hypophosphatemic rickets, ectonucleotide pyrophosphatase/phosphodiesterase1 deficiency, generalized arterial calcification of infancy, pxe (pseudoxanthoma elasticum)